ClinicalTrials.Veeva

Menu

Predictive Factors of Visual Recovery After Paraoptic Tumors Removal (PRONOPTIC)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Tuberculum Sellae Meningioma

Study type

Observational

Funder types

NETWORK

Identifiers

NCT03567486
DCT_2017_18

Details and patient eligibility

About

Paraoptic tumors - including mostly sellar meningiomas, pituitary gland adenomas and craniopharyngiomas - classically affect the visual function. Some preoperative factors, determined on retrospective studies, are known to constitute bad prognostic factors, such as duration of symptoms and retinal nerve fiber layer thinning on OCT. We propose to perform a single center prospective study in which detailed preoperative ophthalmological and radiological criteria will be collected before surgery. Intraoperative information will be noted as well. All these data will be statistically examined regarding the postoperative visual recovery at 3, 6 and 12 months

Enrollment

99 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • tuberculum sellae meningioma surgical indication

Exclusion criteria

  • surgical contra indication MRI contra indication optical disease

Trial design

99 participants in 1 patient group

Tuberculum sellae meningiomas
Description:
Adult patient suffering from tuberculum sellae meningiomas with surgical treatment

Trial contacts and locations

1

Loading...

Central trial contact

Dorian Chauvet

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems